Cardinal Partners

About The Fund

Cardinal Partners is a venture capital firm specializing in seed and early-stage investments, focusing primarily on the life sciences, healthcare, and technology-enabled sectors. Founded in 1996 and based in Princeton, New Jersey, they have a strong track record of building durable, valuable companies across various business and economic cycles. With over 25 years of experience, Cardinal Partners leverages their depth of expertise in healthcare investing and robust networks in the academic, clinical, industry, and investment communities to support innovative enterprises. As an early/growth stage partner to entrepreneurs, Cardinal often steps in as the first institutional investor and sometimes plays a co-founding role. Their portfolio boasts over a hundred growth companies and participation in over 25 IPOs since 1997, culminating in a cumulative market valuation exceeding $15 billion. Cardinal Partners primarily invests in areas that are experiencing waves of change such as healthcare systems, insurance, and regulatory reform, identifying opportunities where technology can drive improvements in care delivery and cost-efficiency. Investments include pioneering work in artificial intelligence, machine learning for medical records, biopharmaceutical research, and next-generation medical devices. Some notable investments involve QPID Health, which was acquired by eviCore healthcare, and Cubist Pharmaceuticals, which was bought by Merck & Co. Cardinal Partners aims to generate superior returns for a diverse group of investors, including university endowments, foundations, pension funds, banks, and insurance companies, thus positioning themselves as a leading venture capital firm for the next generation of healthcare innovation.